Area of research
Genetics · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Genetic Associations and Epidemiology, Diabetes, Cardiovascular Risks, and Lipoproteins, Metabolomics and Mass Spectrometry Studies, and Lipoproteins and Cardiovascular Health.
The Association of Periodontitis With Risk of Prevalent and Incident Metabolic Syndrome.
Value of Multiomics Over Clinical Risk Factors in Hypertension Prediction
Polygenic Risks for Mood Disorders and Economic Well-being: Study of Finnish Cohorts.
Risk Haplotype of BTNL2 Predisposes Male Patients to NSTEMI: A Genetic and Functional Study
Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes
Variation and prognostic potential of the gut antibiotic resistome in the FINRISK 2002 cohort
Gut Microbiome as a Risk Factor for Future CKD
Variation and prognostic potential of the gut antibiotic resistome in the FINRISK 2002 cohort.
Occurrence of coronary events in the absence of traditional risk factors: Understanding residual risk
Updated Reference Limits for Liver Blood Tests With Validation Against Long-Term Liver-Related Outcomes.
Cardiovascular disease outcomes in relation to 25-hydroxyvitamin D and its seasonal variation: Results from the BiomarCaRE consortium.
Associations of alcohol with the human gut microbiome and prospective health outcomes in the FINRISK 2002 cohort.
Microbiome variations in osteoarthritis reflect aging and metabolic factors, not the disease
Genome-wide characterization of circulating metabolic biomarkers
Genome-wide characterization of circulating metabolic biomarkers
Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits
Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits
Prognostic Value of Cardiovascular Biomarkers in the Population
Metabolomic and genomic prediction of common diseases in 700,217 participants in three national biobanks
C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project.
Functional <i>EPAS1</i> / <i>HIF2A</i> missense variant is associated with hematocrit in Andean highlanders
Functional <i>EPAS1</i>/<i>HIF2A</i> missense variant is associated with hematocrit in Andean highlanders.
Integration of polygenic and gut metagenomic risk prediction for common diseases
Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol– or Apolipoprotein B–Related Risk of Coronary Heart Disease
Integration of polygenic and gut metagenomic risk prediction for common diseases.
Role of Gut Microbiota in Statin-Associated New-Onset Diabetes—A Cross-Sectional and Prospective Analysis of the FINRISK 2002 Cohort
X-chromosome and kidney function: evidence from a multi-trait genetic analysis of 908,697 individuals reveals sex-specific and sex-differential findings in genes regulated by androgen response elements
ALT levels, alcohol use, and metabolic risk factors have prognostic relevance for liver-related outcomes in the general population.
Author Correction: Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort.
Associations between gut microbiota and incident fractures in the FINRISK cohort.